Polycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Polycystic Kidney Disease Clinical Trial Report Overview
A total of 238 polycystic kidney disease clinical trials were conducted as of March 2024. The polycystic kidney disease clinical trial report provides a comprehensive understanding of the polycystic kidney disease clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · Central and South America |
Key Countries | · The US
· Japan · The Netherlands · Germany · Belgium |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Otsuka Holdings Co Ltd
· Sanofi · Pfizer Inc · Ipsen SA · Palladio Biosciences Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Polycystic Kidney Disease Clinical Trials Segmentation by Regions and Countries
As of March 2024, Asia-Pacific led the polycystic kidney disease clinical trials landscape with more than 20% of the clinical trials conducted there
The key regions considered for polycystic kidney disease clinical trials analysis are North America, Europe, Asia-Pacific, the Middle East and Africa, and Central and South America.
In the country-wise analysis, the US had the highest number of polycystic kidney disease clinical trials as of March 2024. Australia had the highest average patient enrollment in polycystic kidney disease clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United States held the highest proportion of polycystic kidney disease to Infectious Disease clinical trials as of March 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, and Turkey) countries, China held the highest proportion of polycystic kidney disease to infectious disease clinical trials as of March 2024.
Polycystic Kidney Disease Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Polycystic Kidney Disease Clinical Trials
Polycystic Kidney Disease Clinical Trials Segmentation by Sponsor Types
The key sponsor types for polycystic kidney disease clinical trials are company, institution, and the government. As of March 2024, the company sponsor type conducted more than 50% of polycystic kidney disease clinical trials.
Polycystic Kidney Disease Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Polycystic Kidney Disease Clinical Trials
Polycystic Kidney Disease Clinical Trials - Competitive Landscape
As of March 2024, Otsuka Holdings Co Ltd conducted the highest number of polycystic kidney disease clinical trials
A few of the leading sponsors for polycystic kidney disease clinical trials are:
- Otsuka Holdings Co Ltd
- Sanofi
- Pfizer Inc
- Ipsen SA
- Palladio Biosciences Inc
Polycystic Kidney Disease Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Polycystic Kidney Disease Clinical Trials
Segments Covered in the Report
Polycystic Kidney Disease Clinical Trials Regional Outlook (2024)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Polycystic Kidney Disease Clinical Trials Country Outlook (2024)
- The US
- Germany
- China
- The UK
- Belgium
Polycystic Kidney Disease Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
Sanofi
Pfizer Inc
Ipsen SA
Palladio Biosciences Inc
Regulus Therapeutics Inc
XORTX Therapeutics Inc
ICON Plc
Biogen Inc
Centessa Pharmaceuticals Plc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of polycystic kidney disease clinical trials in March 2024?
Asia-Pacific accounted for the highest number of polycystic kidney disease clinical trials as of March 2024.
-
Which country conducted the highest number of polycystic kidney disease clinical trials in March 2024?
The US conducted the highest number of polycystic kidney disease clinical trials as of March 2024.
-
Which sponsor type was the most prominent in the polycystic kidney disease clinical trials in March 2024?
As of March 2024, the company sponsor type conducted most of the polycystic kidney disease clinical trials.
-
Which are the leading sponsors of polycystic kidney disease clinical trials?
A few of the leading sponsors of polycystic kidney disease clinical trials are Otsuka Holdings Co Ltd, Sanofi, Pfizer Inc, Ipsen SA, and Palladio Biosciences Inc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.